Download FREE Report Sample
Download Free sampleAdvanced therapy medicinal products?(ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer groundbreaking new opportunities for the treatment of disease and injury.
Advanced Therapy Medicinal s Market contains market size and forecasts of Advanced Therapy Medicinal Products in Global, including the following market information:
Global Advanced Therapy Medicinal Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Advanced Therapy Medicinal Products market was valued at 4405.7 million in 2021 and is projected to reach US$ 11190 million by 2028, at a CAGR of 14.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Advanced Therapy Medicinal Products include Spark Therapeutics, Bluebird Bio, Novartis, UniQure, Celgene Corporation, Gilead Lifesciences, Kolon TissueGene, JCR Pharmaceuticals and MEDIPOST, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Advanced Therapy Medicinal Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Advanced Therapy Medicinal Products Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Advanced Therapy Medicinal Products Market Segment Percentages, by Type, 2021 (%)
Cell Therapy
CAR-T Therapy
Gene Therapy
Tissue Engineered Product
Global Advanced Therapy Medicinal Products Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Advanced Therapy Medicinal Products Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Advanced Therapy Medicinal Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Advanced Therapy Medicinal Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Advanced Therapy Medicinal Products revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Advanced Therapy Medicinal Products revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Spark Therapeutics
Bluebird Bio
Novartis
UniQure
Celgene Corporation
Gilead Lifesciences
Kolon TissueGene
JCR Pharmaceuticals
MEDIPOST
Vericel Corporation
PHARMICELL
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
